Results 111 to 120 of about 44,405 (256)

A Biomarker‐Based Classification of Corticobasal Syndrome

open access: yesMovement Disorders, EarlyView.
Abstract Background Corticobasal syndrome (CBS) is a clinically defined syndrome with progressive movement and cortical dysfunction, caused by various underlying pathologies, most commonly tau‐predominant pathologies such as progressive supranuclear palsy and corticobasal degeneration, or Alzheimer's disease (AD).
Carla Palleis   +13 more
wiley   +1 more source

Pilot Study of [11C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET Radiotracer

open access: yesCells
A novel brain positron emission tomography (PET) radioligand, [11C]HY-2-15, has potential for imaging alpha-synuclein aggregations in multiple system atrophy and misfolded tau proteins in tauopathies, based on its high binding affinity in disease brain ...
Chia-Ju Hsieh   +11 more
doaj   +1 more source

Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. [PDF]

open access: yes, 2016
Animal models have shown that tau seeding and propagation are strain- and neural network-specific. The study of preclinical cases is valuable to gain insights into early pathological features of corticobasal degeneration and its progression.
Davey, K   +9 more
core   +2 more sources

Analyzing the ‘Bradykinesia Complex’ in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Bradykinesia is the hallmark sign of parkinsonism. We recently proposed redefining bradykinesia as a complex of motor abnormalities, each reflecting separate pathophysiological elements. Objective To analyze the ‘bradykinesia complex’ in Parkinson's disease (PD) and healthy elderly individuals.
Giulia Paparella   +9 more
wiley   +1 more source

Corticobasal degeneration and corticobasal syndrome: A review

open access: yesClinical Parkinsonism & Related Disorders, 2019
Corticobasal degeneration (CBD) is a rare neurodegenerative disorder. The most common presentation of CBD is the corticobasal syndrome (CBS), which is a constellation of cortical and extrapyramidal symptoms and signs.
Vasilios C. Constantinides   +4 more
doaj   +1 more source

The Utility of Olfactory Testing to Discriminate Parkinson's Disease From Diagnostic Mimics: A Systematic Review and Meta-Analysis. [PDF]

open access: yesEur J Neurol
ABSTRACT Background Hyposmia is present in most patients with Parkinson's disease (PD), whereas olfaction is usually preserved in its diagnostic mimics. To address the limited evidence from smaller studies, we conducted a meta‐analysis on the diagnostic accuracy of olfactory testing in differentiating PD from clinical look‐alikes.
Theyer C   +11 more
europepmc   +2 more sources

Frontrunner in Translation: Progressive Supranuclear Palsy

open access: yesFrontiers in Neurology, 2019
Progressive supranuclear palsy (PSP) is a four-repeat tau proteinopathy. Abnormal tau deposition is not unique for PSP and is the basic pathologic finding in some other neurodegenerative disorders such as Alzheimer's disease (AD), age-related tauopathy ...
Ali Shoeibi, Nahid Olfati, Irene Litvan
doaj   +1 more source

Apathy and impulsivity in frontotemporal lobar degeneration syndromes [PDF]

open access: yes, 2017
Apathy and impulsivity are common and disabling consequences of frontotemporal lobar degeneration. They cause substantial carer distress, but their aetiology remains elusive.
Coyle-Gilchrist, ITS   +8 more
core   +3 more sources

Characteristics of Swallowing Function in People with Parkinson's Disease: A Scoping Review

open access: yesMovement Disorders, EarlyView.
Abstract Background Most individuals with Parkinson's disease (PD) develop dysphagia during the course of their disease. It is crucial to comprehensively understand swallowing characteristics specific to PD for effective treatment. Objectives To systematically analyze and synthesize swallowing characteristics in people with PD compared with healthy ...
Kerstin Erfmann   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy